Table 1.
Baseline pre-operative characteristics of the study population
| Baseline characteristics | |||
|---|---|---|---|
| UG | OFG | p-values | |
| Number | 24 | 38 | |
| Sex (%) | 0.08 | ||
|
Female Male |
62.5 37.5 |
39.5 60.5 |
|
| Age (years) | 52.79 | 51.11 | 0.93 |
| Lens status | 0.51 | ||
|
Phakic Pseudophakic Aphakic |
3 19 2 |
2 34 2 |
|
|
Keratoplasty total (%) Penetrating keratoplasty DMEK DSAEK |
8.33 1 1 0 |
42.10 13 2 1 |
0.03 |
| Macular edema (%) | 12.50 | 2.63 | 0.31 |
| Uveitis location (%) | |||
|
Anterior Intermediate Pan-uveitis |
54 29 17 |
||
| IOP (mmHg) | 35.04 (± 11.85) | 32.63 (± 7.74) | 0.58 |
| Topical agents | 3.08 (± 1.13) | 2.68 (± 1.28) | 0.25 |
| Systemic acetazolamide (%) | 79% | 87% | 0.42 |
| Visual acuity (log MAR) | 0.38 (± 0.42) | 1.12 (± 0.83) | < 0.001 |
|
Glaucoma operations before BI 250 Traculectomy ab interno Trabeuculectomy ab externo Cyclophotocoagulation/cryocoagulation Iridectomy Molteno implant Cypass implant Goniotomy XEN implant SLT |
1.21 (± 0.66) 19 7 0 0 0 0 0 0 1 |
1.74 (± 1.33) 14 14 15 4 1 2 1 1 0 |
0.07 |
| Median follow-up (days) | 592 | 764 | 0.10 |
| Mean uveitis duration to surgery (months) | 146.72 | ||
| Other form of glaucoma (%): | |||
|
Congenital glaucoma Developmental glaucoma Iridocorneal endothelial syndrome Neovascular glaucoma Primary open angle glaucoma Angle closure glaucoma Pseudoexfoliative glaucoma Post-traumatic glaucoma Post-operative glaucoma |
8 3 8 3 26 8 5 13 26 |
||